Page last updated: 2024-11-08

isoflurophate and Myasthenia Gravis

isoflurophate has been researched along with Myasthenia Gravis in 7 studies

Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
QUILLIAM, JP1
HARVEY, AM1
LILIENTHAL, JL1
COMROE, JH1
TODD, J1
NOWELL, PT1
SCOTT, CA1
WILSON, A1
HESS, AR1
ANGEL, RW1
BARRON, KD1
BERNSOHN, J1
GIULIANI, G1
Albuquerque, EX1
Eldefrawi, AT1
Oliveira, AC1
Copio, DS1
Eldefrawi, ME1

Other Studies

7 other studies available for isoflurophate and Myasthenia Gravis

ArticleYear
Di-iso propylfluorophosphonate (DFP) its pharmacology and its therapeutic uses in glaucoma and myasthenia gravis.
    Postgraduate medical journal, 1947, Volume: 23, Issue:260

    Topics: Glaucoma; Humans; Isoflurophate; Myasthenia Gravis

1947
The administration of di-isopropyl fluorophosphate to man; the effects on neuromuscular function in normal subjects and in myasthenia gravis.
    Bulletin of the Johns Hopkins Hospital, 1947, Volume: 81, Issue:4

    Topics: Fluorides; Humans; Isoflurophate; Male; Myasthenia Gravis; Phosphates

1947
The effect of di-isopropyl fluorophosphate (DFP) upon patients with myasthen in gravis.
    The American journal of the medical sciences, 1946, Volume: 212, Issue:6

    Topics: Fluorides; Humans; Isoflurophate; Myasthenia Gravis; Phosphates

1946
Hydrolysis of neostigmine by plasma cholinesterase.
    British journal of pharmacology and chemotherapy, 1962, Volume: 19

    Topics: Ammonium Compounds; Cholinesterases; Hydrolysis; Isoflurophate; Myasthenia Gravis; Neostigmine; Quat

1962
PROTEINS AND ISOZYMES OF ESTERASES AND CHOLINESTERASES FROM SERA OF DIFFERENT SPECIES.
    Clinica chimica acta; international journal of clinical chemistry, 1963, Volume: 8

    Topics: Acetylcholinesterase; Animals; Blood Chemical Analysis; Blood Protein Electrophoresis; Blood Protein

1963
[TREATMENT OF MYASTHENIA].
    Minerva medica, 1964, Jan-27, Volume: 55

    Topics: Adrenocorticotropic Hormone; Cyclopropanes; Epinephrine; Galantamine; Humans; Hypnotics and Sedative

1964
Myasthenia gravis animal model: quantitative analysis of the efficiency of pre- and postjunctional regions of intercostal muscles in rabbits immunized with Torpedo acetylcholine receptor.
    Experimental neurology, 1979, Volume: 66, Issue:1

    Topics: Acetylcholine; Action Potentials; Animals; Disease Models, Animal; Electric Organ; Isoflurophate; Mo

1979